Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

pX333 Citations (28)

Plasmid Article: In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system.
Maddalo D, Manchado E, Concepcion CP, Bonetti C, Vidigal JA, Han YC, Ogrodowski P, Crippa A, Rekhtman N, de Stanchina E, Lowe SW, Ventura A Nature. 2014 Dec 18;516(7531):423-7. doi: 10.1038/nature13902. Epub 2014 Oct 22.
PubMed Journal

Articles Citing pX333

Articles
A lentivirus-free inducible CRISPR-Cas9 system for efficient targeting of human genes. Bisht K, Grill S, Graniel J, Nandakumar J. Anal Biochem. 2017 Aug 1;530:40-49. doi: 10.1016/j.ab.2017.05.001. Epub 2017 May 4. PubMed
Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy. Young CS, Mokhonova E, Quinonez M, Pyle AD, Spencer MJ. J Neuromuscul Dis. 2017;4(2):139-145. doi: 10.3233/JND-170218. PubMed
R-spondins can potentiate WNT signaling without LGRs. Lebensohn AM, Rohatgi R. Elife. 2018 Feb 6;7. pii: 33126. doi: 10.7554/eLife.33126. PubMed
Resistance Mechanisms to Targeted Therapies in ROS1(+) and ALK(+) Non-small Cell Lung Cancer. McCoach CE, Le AT, Gowan K, Jones K, Schubert L, Doak A, Estrada-Bernal A, Davies KD, Merrick DT, Bunn PA Jr, Purcell WT, Dziadziuszko R, Varella-Garcia M, Aisner DL, Camidge DR, Doebele RC. Clin Cancer Res. 2018 Jul 15;24(14):3334-3347. doi: 10.1158/1078-0432.CCR-17-2452. Epub 2018 Apr 10. PubMed
An Inducible DamID System for Profiling Interactions of Nuclear Lamina Protein Component Lamin B1 with Chromosomes in Mouse Cells. Kozhevnikova EN, Leshchenko AE, Pindyurin AV. Biochemistry (Mosc). 2018 May;83(5):586-594. doi: 10.1134/S0006297918050115. PubMed
Control of neural crest multipotency by Wnt signaling and the Lin28/let-7 axis. Bhattacharya D, Rothstein M, Azambuja AP, Simoes-Costa M. Elife. 2018 Dec 6;7. pii: 40556. doi: 10.7554/eLife.40556. PubMed
Pipeline for the generation of gene knockout mice using dual sgRNA CRISPR/Cas9-mediated gene editing. Ghassemi B, Shamsara M, Soleimani M, Kiani J, Rassoulzadegan M. Anal Biochem. 2019 Mar 1;568:31-40. doi: 10.1016/j.ab.2018.12.002. Epub 2018 Dec 26. PubMed
Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease. Khosravi MA, Abbasalipour M, Concordet JP, Berg JV, Zeinali S, Arashkia A, Azadmanesh K, Buch T, Karimipoor M. Eur J Pharmacol. 2019 Jul 5;854:398-405. doi: 10.1016/j.ejphar.2019.04.042. Epub 2019 Apr 27. PubMed
Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031. Sarr A, Bre J, Um IH, Chan TH, Mullen P, Harrison DJ, Reynolds PA. Sci Rep. 2019 May 21;9(1):7643. doi: 10.1038/s41598-019-44089-3. PubMed
A New MicroRNA Cluster Involved in the Reprogramming to a Pluripotent State. Sherstyuk VV, Davletshina GI, Vyatkin YV, Shtokalo DN, Vlasov VV, Zakian SM. Acta Naturae. 2019 Apr-Jun;11(2):92-97. doi: 10.32607/20758251-2019-11-2-92-97. PubMed
CRISPR-Mediated Activation of Endogenous Gene Expression in the Postnatal Heart. Schoger E, Carroll KJ, Iyer LM, McAnally JR, Tan W, Liu N, Noack C, Shomroni O, Salinas G, Gross J, Herzog N, Doroudgar S, Bassel-Duby R, Zimmermann WH, Zelarayan LC. Circ Res. 2020 Jan 3;126(1):6-24. doi: 10.1161/CIRCRESAHA.118.314522. Epub 2019 Nov 15. PubMed
Long Noncoding RNA DRAIC Inhibits Prostate Cancer Progression by Interacting with IKK to Inhibit NF-kappaB Activation. Saha S, Kiran M, Kuscu C, Chatrath A, Wotton D, Mayo MW, Dutta A. Cancer Res. 2020 Mar 1;80(5):950-963. doi: 10.1158/0008-5472.CAN-19-3460. Epub 2020 Jan 3. PubMed
Pannexin-1 mediates fluid shear stress-sensitive purinergic signaling and cyst growth in polycystic kidney disease. Verschuren EHJ, Rigalli JP, Castenmiller C, Rohrbach MU, Bindels RJM, Peters DJM, Arjona FJ, Hoenderop JGJ. FASEB J. 2020 May;34(5):6382-6398. doi: 10.1096/fj.201902901R. Epub 2020 Mar 11. PubMed
Role for carbohydrate response element-binding protein (ChREBP) in high glucose-mediated repression of long noncoding RNA Tug1. Long J, Galvan DL, Mise K, Kanwar YS, Li L, Poungvarin N, Overbeek PA, Chang BH, Danesh FR. J Biol Chem. 2020 May 28. pii: RA120.013228. doi: 10.1074/jbc.RA120.013228. PubMed
Germline engineering of the chicken genome using CRISPR/Cas9 by in vivo transfection of PGCs. Challagulla A, Jenkins KA, O'Neil TE, Morris KR, Wise TG, Tizard ML, Bean AGD, Schat KA, Doran TJ. Anim Biotechnol. 2020 Jul 24:1-10. doi: 10.1080/10495398.2020.1789869. PubMed
Design and Testing of Vector-Producing HEK293T Cells Bearing a Genomic Deletion of the SV40 T Antigen Coding Region. Bae DH, Marino M, Iaffaldano B, Fenstermaker S, Afione S, Argaw T, McCright J, Kwilas A, Chiorini JA, Timmons AE, Reiser J. Mol Ther Methods Clin Dev. 2020 Jul 9;18:631-638. doi: 10.1016/j.omtm.2020.07.006. eCollection 2020 Sep 11. PubMed
Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia/lymphoma syndrome. Liu Y, Cai B, Chong Y, Zhang H, Kemp CA, Lu S, Chang CS, Ren M, Cowell JK, Hu T. Cell Death Dis. 2020 Oct 20;11(10):884. doi: 10.1038/s41419-020-03098-1. PubMed
Palmitate-Induced IRE1-XBP1-ZEB Signaling Represses Desmoplakin Expression and Promotes Cancer Cell Migration. Nath A, Oak A, Chen KY, Li I, Splichal RC, Portis J, Foster S, Walton SP, Chan C. Mol Cancer Res. 2021 Feb;19(2):240-248. doi: 10.1158/1541-7786.MCR-19-0480. Epub 2020 Oct 26. PubMed
In Vivo Inhibition of Marek's Disease Virus in Transgenic Chickens Expressing Cas9 and gRNA against ICP4. Challagulla A, Jenkins KA, O'Neil TE, Shi S, Morris KR, Wise TG, Paradkar PN, Tizard ML, Doran TJ, Schat KA. Microorganisms. 2021 Jan 13;9(1). pii: microorganisms9010164. doi: 10.3390/microorganisms9010164. PubMed
Marker counter-selection via CRISPR/Cas9 co-targeting for efficient generation of genome edited avian cell lines and germ cells. Challagulla A, Shi S, Nair K, O'Neil TE, Morris KR, Wise TG, Cahill DM, Tizard ML, Doran TJ, Jenkins KA. Anim Biotechnol. 2021 Mar 2:1-11. doi: 10.1080/10495398.2021.1885428. PubMed
An optimized CRISPR/Cas9 approach for precise genome editing in neurons. Fang H, Bygrave AM, Roth RH, Johnson RC, Huganir RL. Elife. 2021 Mar 10;10. pii: 65202. doi: 10.7554/eLife.65202. PubMed

Associated Plasmids

Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling. Huang H, Hu J, Maryam A, Huang Q, Zhang Y, Ramakrishnan S, Li J, Ma H, Ma VWS, Cheuk W, So GYK, Wang W, Cho WCS, Zhang L, Chan KM, Wang X, Chin YR. Nat Commun. 2021 Apr 14;12(1):2242. doi: 10.1038/s41467-021-22445-0. PubMed
Role of cytoplasmic localization of maspin in promoting cell invasion in breast cancer with aggressive phenotype. Sakabe T, Wakahara M, Shiota G, Umekita Y. Sci Rep. 2021 May 31;11(1):11321. doi: 10.1038/s41598-021-90887-z. PubMed
ANLN Enhances Triple-Negative Breast Cancer Stemness Through TWIST1 and BMP2 and Promotes its Spheroid Growth. Maryam A, Chin YR. Front Mol Biosci. 2021 Jul 1;8:700973. doi: 10.3389/fmolb.2021.700973. eCollection 2021. PubMed
IFNalpha and beta Mediated JCPyV Suppression through C/EBPbeta-LIP Isoform. May D, Bellizzi A, Kassa W, Cipriaso JM, Caocci M, Wollebo HS. Viruses. 2021 Sep 26;13(10). pii: v13101937. doi: 10.3390/v13101937. PubMed
TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis. Hu J, Lai Y, Huang H, Ramakrishnan S, Pan Y, Ma VWS, Cheuk W, So GYK, He Q, Geoffrey Lau C, Zhang L, Cho WCS, Chan KM, Wang X, Rebecca Chin Y. Br J Cancer. 2022 Jan;126(1):57-71. doi: 10.1038/s41416-021-01596-3. Epub 2021 Oct 30. PubMed
CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination. Herskovitz J, Hasan M, Patel M, Blomberg WR, Cohen JD, Machhi J, Shahjin F, Mosley RL, McMillan J, Kevadiya BD, Gendelman HE. EBioMedicine. 2021 Nov;73:103678. doi: 10.1016/j.ebiom.2021.103678. Epub 2021 Nov 10. PubMed
CRISPR-Cas9 effectors facilitate generation of single-sex litters and sex-specific phenotypes. Douglas C, Maciulyte V, Zohren J, Snell DM, Mahadevaiah SK, Ojarikre OA, Ellis PJI, Turner JMA. Nat Commun. 2021 Dec 3;12(1):6926. doi: 10.1038/s41467-021-27227-2. PubMed

If you have published an article using this plasmid, please email us at [email protected] to have your article added to this page.